drugset / Trial / NCT06074094

Probiotic Supplementation IN NAFLD Patients

NCT06074094 ↗

Phase 4 Completed 50 enrolled Ain Shams University
Non-randomizedSequentialSingle-blindTreatment

Summary

this study aimed to evaluate the effectiveness of Probiotics supplementation (lactobacillus) on NAFLD fibrosis score.

Timeline

Start
2021-09-12
Primary completion
2022-12-31
Completion
2023-03-01

Outcome

Missed primary endpoint

paper However, there was no significant difference in NAFLD fibrosis score between the two groups. PMID 39379797 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject lactobacillus LS Other / unclassified — Oral

Indications